Jeff Hrkach is Senior Vice President of Technology Development at Frequency Therapeutics, leading the CMC, pharmaceutical development and delivery research efforts. Jeff joined Frequency from Moderna, where he was Head of Delivery Innovation. Prior to Moderna, Jeff held several senior leadership positions, including Chief Technology Officer, at BIND Therapeutics. Jeff made his postdoctoral research with Pr. Robert Langer at MIT and has over 25 peer-reviewed scientific publications and more than 50 U.S. patents/applications. He received his Ph.D. in Chemistry and M.S. in Polymer Science from Carnegie Mellon University and his B.S. in Chemistry from the Philadelphia College of Pharmacy and Science.